This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Czechs sign Korean nuclear deal despite EU’s subsidy warnings

By Lewis Crofts, Joanna Sopinska and Nicholas Hirst ( June 5, 2025, 14:18 GMT | Insight) -- Korea Hydro & Nuclear Power and the Czech government have signed a deal to provide nuclear reactors at the Dukovany power plant less than a month after the European Commission warned such a move would breach a duty of “sincere cooperation” during a foreign-subsidy probe. Earlier this week, the Supreme Administrative Court in the Czech Republic lifted an interim injunction stopping signature of the deal. The EU executive today said it was continuing its “preliminary investigation” under subsidy rules.Korea Hydro & Nuclear Power and the Czech government have signed a deal to provide nuclear reactors at the Dukovany power plant less than a month after the European Commission warned such a move would breach a duty of “sincere cooperation” during an investigation into potentially distortive foreign subsidies....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections